Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_assertion type Assertion NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_head.
- NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_assertion description "[We investigated the mRNA levels of hepcidin (HAMP), HFE, neogenin (NEO1), transferrin receptor 1 (TFRC), transferrin receptor 2 (TFR2), and hemojuvelin (HFE2) in normal human brain, brain tumors, and astrocytoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_provenance.
- NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_assertion evidence source_evidence_literature NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_provenance.
- NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_assertion SIO_000772 19386095 NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_provenance.
- NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_assertion wasDerivedFrom befree-20150227 NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_provenance.
- NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_assertion wasGeneratedBy ECO_0000203 NP975134.RAA7ctnfLfxPK3e0sHz0RbVmCD042vKq9tOjilD-YqJag130_provenance.